论文部分内容阅读
糖尿病患者的降压问题一直是学术界关注和争论的话题。学术界在这一方面达成的共识只是降压治疗对伴有高血压的糖尿病患者有肯定的益处,但这种益处范围多大,仅仅是心血管方面,还是包括脑血管、肾脏病、眼等各个系统以及总病死率等终点事件,则存有争议;同时这种益处是否可以外推到对非高血压的糖尿病患者,也一直悬而未决。《Cochrane图书馆》的这篇文章对在糖尿病患者身上所进行的降压试验进行系统的评估,特予摘译,以供广大的临床医生参考。
Antihypertensive patients with diabetes has been the topic of academic concern and controversy. Academics have reached a consensus in this respect that antihypertensive treatment only has certain benefits for people with diabetes mellitus and hypertension, but the range of benefits is only cardiovascular, including cerebrovascular, kidney disease, and eye diseases System and overall mortality and other endpoints, it is controversial; at the same time whether this benefit can be extrapolated to non-hypertensive patients with diabetes, has been unresolved. This article in the Cochrane Library provides a systematic review of the antihypertensive trial in patients with diabetes and is intended to be translated for general reference by clinicians.